1. Transcatheter aortic valve-in-surgical aortic valve for a patient with repeated healed endocarditis: a case report
- Author
-
Yusuke Takei, Ryujiro Suzuki, Ikuko Shibasaki, Michiaki Tokura, Takahisa Nasuno, Hiroko Yazawa, Mayo Wada, Fumiya Saito, Shigeru Toyoda, and Hirotugu Fukuda
- Subjects
Transcatheter valve replacement ,Transcatheter aortic valve in a surgical aortic valve ,Stentless valve ,Prosthetic valve endocarditis ,Healed infective endocarditis ,Surgery ,RD1-811 - Abstract
Abstract Background Transcatheter valve replacement is contraindicated in patients with active infective endocarditis. However, few reports suggest that it could be beneficial for high-risk surgical patients with healed infective endocarditis. Here, we report a case of a surgical transcatheter aortic valve in a patient with healed repeated prosthetic valve endocarditis using a stentless valve. Case presentation A 79-year-old female who underwent the Bentall procedure using a stentless valve and coronary artery bypass grafting for annuloaortic ectasia 22 years ago was hospitalized for stage II bioprosthetic valve failure. The patient had a history of prosthetic valve endocarditis three times: the first and second prosthetic valve endocarditis occurred 15 years ago, and the third prosthetic valve endocarditis occurred 3 years ago. The causative organisms were Campylobacter fetus and Enterococcus faecalis. With appropriate antibiotic therapy, the lesion was localized and healed completely without valve destruction; however, the patient developed rapid aortic regurgitation. Based on a review of the patient’s history of prosthetic valve endocarditis, the absence of signs of infection, and clinical findings of transesophageal echocardiography and computed tomography, a diagnosis of structural valve deterioration with healed infective endocarditis was made. Subsequently, a transcatheter aortic valve in a surgical aortic valve using a balloon-expandable type was performed, because the patient had a high surgical risk of 12.7%. The patient’s postoperative course was uneventful. At the 1-year follow-up, there were no signs of infection or valve abnormalities. Conclusions Transcatheter valve replacement can be a treatment option for high-risk surgical patients with healed limited lesions in infective endocarditis.
- Published
- 2023
- Full Text
- View/download PDF